Avior Bio is a clinical-stage pharmaceutical company advancing therapies in pruritus (itch) in chronic liver disease (CLD) and atopic dermatitis (eczema). Today, there are no FDA-approved therapies for CLD-associated pruritus in the USA, and one very expensive, biological therapeutic injection for eczema, namely Dupixent®. Avior strives to seek the first-to-market status for the targeted indication of CLD-associated pruritus...
Avior Bio is a clinical-stage pharmaceutical company advancing therapies in pruritus (itch) in chronic liver disease (CLD) and atopic dermatitis (eczema). Today, there are no FDA-approved therapies for CLD-associated pruritus in the USA, and one very expensive, biological therapeutic injection for eczema, namely Dupixent®. Avior strives to seek the first-to-market status for the targeted indication of CLD-associated pruritus and hopes that its drug will be the standard of care in the treatment of pruritus in eczema.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.